SEC Form D filing
Mati Therapeutics Inc., 2025-09-23
An SEC Form D private-offering notice from Austin, TX, a $4,896,500 filer-stated offering target in Biotech. Filed 2025-09-23. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Mati Therapeutics Inc. Verified via SEC Form D
Filed 2025-09-23Filed to raise $4,896,500First money in 2025-09-12Raised so far $2,649,815HQ (as filed) Austin, TXSector Biotech machine-classified from the filing aloneStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 9 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Mortgage Collaborative LLC, 2025-09-24, $105K, Austin, TX
- Tinos Therapeutics, Inc., 2025-09-26, $4M, Cambridge, MA
- Morningstar Minerals - West II, LP, 2025-09-23, $6.6M, Dallas, TX
- Apnimed, Inc., 2025-09-24, $35M, Cambridge, MA
- Hera Biotech, Inc., 2025-09-23, $5M, San Antonio, TX
- Dewpoint Therapeutics, Inc., 2025-09-23, $82.3M, Boston, MA
- Sonoro Gold Corp., 2025-09-23, $207K, West Vancouver, BC, Canada
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.